A long-term multicentre assessment of the safety and tolerability of calcitriol ointment in the treatment of chronic plaque psoriasis

British Journal of Dermatology

Volumn 135, Issue 3, 1996, Pages 385-389

  Langner, A ^a   Ashton, P ^b   Van De Kerkhof, P C M ^b   Verjans, H ^b  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL;

ADULT; ANIMAL EXPERIMENT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; HUMAN; HYPERCALCEMIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PSORIASIS; SKIN IRRITATION; TOPICAL DRUG ADMINISTRATION;

EID: 0029826935     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1996.tb01500.x     Document Type: Article

References (19)

1. 3. Endocrinology 1983; 113: 1950-7.
2. 3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes grown in serum-free conditions. J Invest Dermatol 1986; 86: 709-14.
3. 3 can be safe and effective therapy of psoriasis. J Am Acad Dermatol 1988; 19: 516-28.
4. 3. J Clin Endocrinol Metab 1983; 56: 824-9.
5. 3: a novel immunoregulatory hormone. Science 1984; 224: 1438-40.
6. 3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells. J Clin Invest 1984; 74: 657-61.
7. 3 ointment. In: Vitamin D, Gene Regulation, Structure-Function Analysis and Clinical Application (Norman AW, Bouillon R, Thomasset M. eds). Berlin: Walter de Gruyter, 1991; 430-1.
8. 3 (calcitriol) ointment in psoriasis. J Dermatol Treat 1992; 3: 177-80.
9. Langner A, Verjans H, Stapór V et al. Topical calcitriol in the treatment of chronic plaque psoriasis: a double-blind study. Br J Dermatol 1993; 128: 566-71.
10. 3 (calcitriol) is an effective and reliable therapy to cure skin lesions in psoriatic children. Eur J Pediatr 1993; 152: 389-92.
11. 3) ointment in psoriasis, a safety tolerance and efficacy multicentre study. Dermatology 1994; 188: 135-9.
12. Fredriksson T, Lassus A, Salde L. Reproducibility of clinical trials of topical glucocorticosteroids. Int J Dermatol 1983; 22: 536-9.
13. R ) 0.1% ointment in the treatment of patients suffering from atopic dermatitis. J Int Med Res 1986; 14: 85-90.
14. R (1% hydrocortisone) ointment. Clin Trials J 1988; 25: 278-84.
15. 3: a cell biological study. Br J Dermatol 1993; 128: 666-73.
16. Fredriksson T, Pettersson U. Severe psoriasis - oral therapy with a new retinoid. Dermatologica 1978; 157: 1238-44.
17. Sips AJAM, Netelenbos JC, Barto R et al. Topically applied low-dose calcitriol has no calciotropic effect in patients with stable plaque psoriasis. J Am Acad Dermatol 1994; 30: 966-99.
18. Ramsay CA, Berth-Jones J. Brundin G et al. Long-term use of topical calcipotriol in chronic plaque psoriasis. Dermatology 1994; 189: 260-4.
19. Schmoll M, Henseler T, Christophers E. Evaluation of PUVA, topical corticosteroids and the combination of both in the treatment of psoriasis. Br J Dermatol 1978; 99: 693-702.